<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04972500</url>
  </required_header>
  <id_info>
    <org_study_id>PREOP2</org_study_id>
    <nct_id>NCT04972500</nct_id>
  </id_info>
  <brief_title>The Influence of Fasting on Selected Hemodynamic Parameters Measured in a Non-invasive Way</brief_title>
  <official_title>The Influence of Fasting on Selected Hemodynamic Parameters Measured in a Non-invasive Way</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Gdansk</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Gdansk</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preoperative fasting is considered to be refraining from taking meals for at least 6 hours&#xD;
      and clear fluids for at least 2 hours before anesthesia. On the one hand, it is a procedure&#xD;
      that reduces the risk of aspiration of chyme and the occurrence of Mendelson's syndrome, and&#xD;
      on the other hand, it is one of the causes of water and carbohydrate disturbances in patients&#xD;
      undergoing general anesthesia. Most of them experience some degree of dehydration in the&#xD;
      preoperative period. It is associated with a worse prognosis. Due to the negative impact of&#xD;
      fasting on homeostasis, as well as significant changes in heart rate in participants in the&#xD;
      previous study, we decided to measure the hemodynamic parameters during fasting. The&#xD;
      development of impedance cardiography techniques enables the measurement of these parameters&#xD;
      by a non-invasive method.&#xD;
&#xD;
      After obtaining the participant's written consent to participate in the study, the first&#xD;
      measurement of body weight, blood pressure using a non-invasive method and hemodynamic&#xD;
      parameters using a non-invasive impedance cardiography method using the Niccomo ™ device&#xD;
      (Medizinische Messtechnik GmbH) will be performed in the evening. The subject will then be&#xD;
      asked to refrain from food for at least 10 hours and fluid for 6 hours before the next&#xD;
      measurement. The next morning, another measurement will be made and the participant will be&#xD;
      randomly assigned to one of two groups: subjects in the first group will be asked to refrain&#xD;
      from eating and drinking for another 2 hours, while subjects in the second group per os will&#xD;
      receive 400 milliliters of PreOp® (Nutricia ™ preparation intended for preoperative dietary&#xD;
      management in surgical patients, containing carbohydrates and electrolytes). After another&#xD;
      two hours, the third measurement of the tested parameters will be performed. The obtained&#xD;
      results will be subjected to statistical analysis consisting in comparing the values of&#xD;
      hemodynamic parameters between the studied groups at appropriate measurement points.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 12, 2021</start_date>
  <completion_date type="Actual">November 4, 2021</completion_date>
  <primary_completion_date type="Actual">November 4, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in cardiac index (CI)</measure>
    <time_frame>Changes form baseline after 10 hours of fasting and after 2 hours of pre-op administration</time_frame>
    <description>Cardiac index will be measured non-invasively with Niccomo™(Medizinische Messtechnik GmbH) device.&#xD;
Cardiac index will be measured in l/min/m^2 (liters per minute per square meter).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in systemic vascular resistance index (SVRI)</measure>
    <time_frame>Changes form baseline after 10 hours of fasting and after 2 hours of pre-op administration</time_frame>
    <description>Systemic vascular resistance index will be measured non-invasively with Niccomo™(Medizinische Messtechnik GmbH) device.&#xD;
Systemic vascular resistance index will be measured in dyn*s*cm^-5*m^2 (dyne multiply by second multiply by centimeters to the power of minus 5 multiply by square meter)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in stroke volume (SV)</measure>
    <time_frame>Changes form baseline after 10 hours of fasting and after 2 hours of pre-op administration</time_frame>
    <description>Stroke volume will be measured non-invasively with Niccomo™(Medizinische Messtechnik GmbH) device.&#xD;
Stroke volume will be measured in mL (milliliters).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in heart rate (HR)</measure>
    <time_frame>Changes form baseline after 10 hours of fasting and after 2 hours of pre-op administration</time_frame>
    <description>Heart rate will be measured non-invasively with Niccomo™(Medizinische Messtechnik GmbH) device.&#xD;
Heart rate will be measured in 1/min (beats per minute).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Perioperative Complication</condition>
  <condition>Hemodynamic Instability</condition>
  <arm_group>
    <arm_group_label>Pre-op</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nutricia Pre-op, 400 milliliters, per os</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nutricia Pre-op, 400 milliliters, per os</intervention_name>
    <description>After 10 hours of fasting participants will receive per os 400 milliliters of Nutricia Pre-op</description>
    <arm_group_label>Pre-op</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiology (ASA) general condition assessment 1 or 2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic kidney disease&#xD;
&#xD;
          -  Circulatory failure&#xD;
&#xD;
          -  Lung diseases&#xD;
&#xD;
          -  Diseases of the heart valves&#xD;
&#xD;
          -  History of hypoglycaemic episodes or any carbohydrate disturbance.&#xD;
&#xD;
          -  Height less than 120 cm or greater than 230 cm&#xD;
&#xD;
          -  Body weight less than 30 kg or greater than 155 kg.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Radoslaw Owczuk, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Gdansk</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Gdansk - Departament of Anesthesiology and Intensive Care</name>
      <address>
        <city>Gdańsk</city>
        <state>Pomorskie</state>
        <zip>80-210</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>July 9, 2021</study_first_submitted>
  <study_first_submitted_qc>July 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 22, 2021</study_first_posted>
  <last_update_submitted>November 5, 2021</last_update_submitted>
  <last_update_submitted_qc>November 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Gdansk</investigator_affiliation>
    <investigator_full_name>Radosław Owczuk</investigator_full_name>
    <investigator_title>Clinical Professor, Head of Department of Anaesthesiology and Intensive Care</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

